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We report a case of Pneumocystis jirovecii transmission 
from colonized grandparents to their infant granddaughter. 
Genotyping of P. jirovecii showed the same genotypes in 
samples from the infant and her grandparents. These fi nd-
ings support P. jirovecii transmission from immunocompe-
tent carrier adults to a susceptible child. 
Pneumocystis jirovecii is an atypical fungus that causes pneumonia in immunosuppressed persons; many ques-
tions about its epidemiology and transmission remain 
unanswered (1,2). Animal sources for P. jirovecii can be 
excluded because the Pneumocystis organisms that infect 
mammalian species are characterized by strong, close host-
species specifi city (3). Similarly, an environmental reser-
voir of infection has not been found (4). Airborne trans-
mission has been demonstrated in animal models, but the 
route of transmission of Pneumocystis organisms among 
humans is unclear (5). P. jirovecii DNA has been identifi ed 
in ambient air, and airborne transmission between humans 
is likely (4). This hypothesis is supported by reports of case 
clusters of pneumocystis pneumonia (PcP) among immu-
nosuppressed patients, transmission of Pneumocystis DNA 
from PcP patients to healthcare workers, and transmission 
of Pneumocystis infection from a mother with PcP to her 
susceptible child (6–10).
Use of highly sensitive PCR technologies has enabled 
detection of low levels of P. jirovecii in respiratory samples 
from persons who do not have PcP. Many terms—coloni-
zation, carriage, asymptomatic infection, and subclini-
cal infection—have been used to describe these fi ndings. 
Studies have shown that persons who have underlying HIV 
infection or other causes of immunosuppression and those 
who are not immunosuppressed but have chronic lung dis-
ease may often be colonized by P. jirovecii (11–13). Fur-
ther hypotheses claim that these groups may play a role in 
person-to-person transmission and that they may serve as 
reservoirs for future Pneumocystis infection in other sus-
ceptible persons; however, this hypothesis has not been 
proven.
The Study
A 6-month-old female infant was admitted to Virgen 
del Rocío University Hospital, Seville, Spain, with a histo-
ry of nonproductive cough and diffi culty breathing. She had 
been born by vaginal delivery after 40 weeks of gestation, 
birth weight was 3,490 g, and she had been breast-fed for 2 
months. Her mother was healthy and HIV negative. At the 
time of examination, the infant was afebrile, weighed 4.5 
kg (<3rd percentile), and was 62 cm long (<3rd percentile). 
Respiratory rate was 70 breaths/min; oxygen saturation 
(by pulse oximetry) was 89%. Fine crackles were heard in 
both lungs. She had neither lymphadenopathy nor viscero-
megaly. Diagnostic testing found leukocyte count 12,600 
cells/mm3, CD4+ cells within normal limits, and no immu-
nosupression. Serologic and molecular test results for HIV 
infection were negative. Chest radiograph showed diffuse 
interstitial infi ltrates suggestive of PcP.
P. jirovecii DNA was detected in nasopharyngeal aspi-
rate samples by amplifying the mitochondrial large-subunit 
gene of rRNA with nested PCR. No other infections were 
detected by culture, molecular tests, or serologic tests. The 
infant was treated with high-dose trimethoprim-sulfame-
thoxazole and adjuvant steroids. She did well and was dis-
charged a month later.
To determine the origin of the infant’s infection, we 
investigated all persons who lived with her, i.e., parents, 
brother, and grandparents. Each person underwent clinical 
and epidemiologic examination and submitted oropharyn-
geal samples for analysis. Informed consent was obtained 
from all persons, and the study was approved by the hospi-
tal’s ethics committee.
The infant’s mother, father, and brother were healthy. 
Her grandmother and grandfather reported a history of 
rheumatoid arthritis and chronic bronchitis, respectively. 
None had pneumonia symptoms at the time of the study.
Identifi cation of P. jirovecii colonization was carried 
out by analyzing oropharyngeal samples with nested PCR 
at the gene encoding the mitochondrial large-subunit rRNA, 
with primers pAZ102-E and pAZ102-H in the fi rst-round 
amplifi cation, followed by pAZ102-X and pAZ102-Y in 
the second-round amplifi cation (12). Pneumocystis DNA 
was extracted after samples were digested with proteinase 
K at 56ºC by using a commercial kit (QIAGEN, Hilden, 
Germany). To prevent contamination, pipettes with fi l-
DISPATCHES
1116 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 7, July 2008
*Virgen del Rocío University Hospital, Seville, Spain; and †Net-
work Center for Biomedical Research in Epidemiology and Public 
Health, Seville
DOI: 10.3201/eid1407.071431 
Pneumocystis jirovecii Transmission from Carriers
ters were used for all manipulations. DNA extraction and 
preparation of the reaction mixture were performed in 2 
different rooms under separate laminar-fl ow hoods. PCR 
and analysis of PCR products were performed in another 
room. Controls were run simultaneously with respiratory 
samples. Positive controls were bronchoalveolar lavage 
specimens from PcP patients; negative controls were auto-
claved water in the PCR mixture in the absence of the DNA 
template controls.
All samples that were positive according to nested 
PCR were sequenced; polymorphisms at nucleotide posi-
tions 85 and 248 were detected by direct sequencing (12). 
The nested PCR products were purifi ed by using Sephacryl 
S-400 columns (Amersham Pharmacia Biotech AB, Uppsa-
la, Sweden) and reamplifi ed with ABI Prism dRhodamine 
Terminator Cycle Sequencing Ready Reaction Kit (PE Ap-
plied Biosystems, Foster City, CA, USA). Then for each 
reaction, 5 μL of PCR product, 4 μL of terminator ready 
reaction mix, and 3 pmol/L of primer were added. The ex-
tension products were purifi ed by ethanol precipitation pro-
cedure to remove the excess dye terminators. Each sample 
pellet was resuspended in 12.5 μL of template suppression 
reagent and heated at 95ºC for 3 min to denature the prod-
uct. Electrophoresis was carried out on the ABI prism 310 
sequencer (PE Applied Biosystems) in accordance with the 
manufacturer’s recommendations. The sequenced DNA 
fragments were analyzed by Sequence Navigator version 
1.0.1 (PE Applied Biosystems).
P. jirovecii DNA was found in oropharyngeal samples 
from the infant’s grandparents but not her parents or broth-
er. Genotype 1 (85C/248C) was identifi ed in the infant and 
in her grandparents. Moreover, coinfection with genotype 
3 (85T/248C) was detected in the grandfather. In addition, 
P. jirovecii dihydropteroate synthase locus was analyzed in 
the samples from the infant and her grandparents by PCR 
restriction fragment-length polymorphism, as described 
(12). Wild dihydropteroate synthase genotype was detected 
in all samples.
Conclusions
This study provides molecular evidence of P. jirovecii 
transmission from human immunocompetent asymptomatic 
carriers to a susceptible host, who developed PcP. We can-
not exclude the possibility that the cases described were in-
fected by the same environmental source; however, an exo-
saprophytic form of P. jirovecii has not been found (4).
P. jirovecii colonization has been shown in pregnant 
women, and their role as contagious sources for their sus-
ceptible newborn infants has been suggested (14). In our 
case, mother-to-infant transmission can be ruled out be-
cause the infant’s mother was not colonized by P. jirovecii. 
An alternative explanation, but less probable considering 
the time course of the clinical symptoms, is that the infant 
acquired the infection in the hospital during delivery and 
was the source of infection for her grandparents. However, 
her grandfather was colonized by genotypes 1 and 3, and 
the infant had only genotype 1.
We hypothesize that the infant was infected by P. 
jirovecii through close contact with her grandparents be-
cause they looked after the child full time and lived in the 
same house. In comparison with animal model experi-
ments on transmission of Pneumocystis infection (5), the 
airborne transmission of P. jirovecii from the grandfather 
to the grandmother and the infant is the most probable ex-
planation, especially in view of the high prevalence of P. 
jirovecii colonization of persons with chronic bronchial 
disease in our area and the grandfather’s sputum produc-
tion associated with this condition (15).
This study provides molecular evidence that trans-
mission of P. jirovecii from colonized immunocompetent 
carrier hosts to susceptible persons may occur. The role of 
persons with chronic pulmonary disease who are colonized 
with P. jirovecii as major reservoirs and sources of infec-
tion warrants further investigation.
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